Next Quarterly Earnings
Thursday, July 30, 2026
CW 31
Pre-Market
In 17 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals, a leading US biopharmaceutical company, is revolutionizing medicine through RNA interference (RNAi). The company develops innovative RNAi therapeutics and medicines for rare genetic diseases and other serious conditions, aiming to improve the lives of patients globally.
Frequently asked questions
When will Alnylam Pharmaceuticals report its next quarterly earnings?
Alnylam Pharmaceuticals is scheduled to report its next quarterly earnings on 07/30/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Alnylam Pharmaceuticals last report quarterly earnings?
Alnylam Pharmaceuticals last reported quarterly earnings on 4/30/2026 (Q2 2026). Earnings per share (EPS) came in at 1.51 USD.
How does Alnylam Pharmaceuticals stock react to earnings?
Across its last 4 earnings reports, Alnylam Pharmaceuticals stock moved by ±3.5% on average the following day. The largest reaction was -6.7% on 10/30/2025; 1 of 4 reactions were positive.
How often has Alnylam Pharmaceuticals beaten expectations?
Alnylam Pharmaceuticals has beaten analyst EPS estimates in 3 of its last 4 evaluated quarters (beat rate: 75%).
How do I add the Alnylam Pharmaceuticals earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±3.5%
Avg. next-day move
-6.7%
Largest move (10/30/2025)
25%
Share of positive reactions
±5.3%
Avg. move after 7 days
Basis: price reactions to the last 4 report dates (close to close).
Estimates vs. results
3/4
Quarters above estimates
75%
Beat rate
+11.5%
Avg. EPS surprise
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Alnylam Pharmaceuticals
Country
🇺🇸
Index membership
More Financial Information